Tinnitech International is an innovative Italian start-up founded by a group of high-profile investors and managers who developed the first ‘synchronous multimodal therapy’ to treat tinnitus with a versatile, effective and long-lasting method.
Our members
Investor, Medical Sector “Fin Posillipo S.p.A. – holding company of the Petrone group. The company operates globally in the field of pharmaceutical distribution and production. With a turnover of about 537 million, it has a direct presence on the national territory, in Spain, Ireland, Singapore, the United States, Germany and Portugal.”
Financial holding investor, medical sector Over 40 years of activity in the intermediate distribution of pharmaceutical products, export of drugs on a European scale, purchase of pharmaceutical molecules, research and development of food supplements. Turnover of 250 million, 300 employees and collaborators, 50,000 square metres of warehouses.
Pier Vincenzo Colli
Investor Manager 40 years of experience within Healthcare & Pharma companies. He has held top positions in multinationals such as IQVIA, PHARMACIA-UPJHON, NYCOMED, TAKEDA.
For the last 10 years he has been CEO of the ALFASIGMA group. He is currently a strategic consultant and private equity investor in the Healthcare/Biopharmaceutical sector.